<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">Data focused on viral respiratory infections in bDMARD cohort are still very limited. The incidence of influenza-like infections observed in a cohort of 159 Italian patients treated with bDMARDs during the influenza season 2009â€“2010 was higher than the value reported in a wide sample of Italian population in the same period, even though no important complications or hospitalizations have been reported [
 <xref rid="bb0310" ref-type="bibr">62</xref>]. Overall, post-marketing experience is relatively reassuring that anti-TNF treated patients may not be at any specifically increased risk of influenza and that severe adverse outcomes, including death, do not appear to be exceedingly frequent [
 <xref rid="bb0315" ref-type="bibr">63</xref>].
</p>
